QYB timeline
Every QYB batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| QYB-2607-L4875 | PT-141 (Bremelanotide) | 07 Jul 2026 | 2026-Q3 | 5 | 99.72 | 0.77 | 99.90 | +0.18 | |
| QYB-2605-H3558 | Ipamorelin | 01 May 2026 | 2026-Q3 | 3 | 99.84 | 0.12 | 99.90 | +0.06 | |
| QYB-2604-B4920 | Retatrutide | 25 Apr 2026 | 2026-Q3 | 10 | 98.50 | 1.59 | 98.19 | -0.31 | |
| QYB-2602-X4422 | GHRP-6 | 20 Feb 2026 | 2026-Q1 | 6 | 99.33 | 0.30 | 99.62 | +0.29 | |
| QYB-2601-D3993 | BPC-157 | 27 Jan 2026 | 2026-Q2 | 13 | 99.90 | 0.56 | 99.90 | 0.00 | |
| QYB-2601-V4429 | Oxytocin | 17 Jan 2026 | 2026-Q2 | 12 | 99.69 | 0.42 | 99.90 | +0.21 | |
| QYB-2512-R5194 | TB-500 | 27 Dec 2025 | 2026-Q1 | 2 | 99.89 | 0.03 | 99.66 | -0.23 | |
| QYB-2512-A4980 | Humanin (HNG) | 14 Dec 2025 | 2026-Q1 | 9 | 99.27 | 0.59 | 98.67 | -0.60 | |
| QYB-2512-H4662 | SS-31 (Elamipretide) | 05 Dec 2025 | 2026-Q2 | 1 | 99.61 | n<2 | 99.88 | +0.27 | |
| QYB-2511-Y4275 | ARA-290 | 09 Nov 2025 | 2025-Q4 | 3 | 99.66 | 0.42 | 99.90 | +0.24 | |
| QYB-2511-V4403 | Liraglutide | 05 Nov 2025 | 2026-Q2 | 1 | 99.03 | n<2 | 99.32 | +0.29 | |
| QYB-2511-V5408 | Thymosin α1 | 04 Nov 2025 | 2026-Q1 | 12 | 99.76 | 0.53 | 99.90 | +0.14 | |
| QYB-2510-D4215 | GHRP-2 | 07 Oct 2025 | 2025-Q4 | 10 | 99.05 | 0.93 | 98.78 | -0.27 | |
| QYB-2510-R4608 | BPC-157 | 06 Oct 2025 | 2026-Q1 | 6 | 99.82 | 0.46 | 99.15 | -0.67 | |
| QYB-2508-E5277 | AOD-9604 | 20 Aug 2025 | 2026-Q1 | 12 | 99.52 | 0.68 | 99.64 | +0.12 | |
| QYB-2508-M5189 | BPC-157 | 18 Aug 2025 | 2025-Q4 | 8 | 99.87 | 0.35 | 99.74 | -0.13 | |
| QYB-2507-T4628 | Tirzepatide | 28 Jul 2025 | 2025-Q4 | 13 | 99.23 | 0.85 | 99.64 | +0.41 | |
| QYB-2507-R4727 | Retatrutide | 28 Jul 2025 | 2025-Q4 | 15 | 98.43 | 1.27 | 98.79 | +0.36 | |
| QYB-2506-B4259 | BPC-157 | 08 Jun 2025 | 2025-Q4 | 3 | 99.93 | 0.26 | 99.90 | -0.03 | |
| QYB-2505-C4807 | CJC-1295 (no DAC) | 08 May 2025 | 2025-Q3 | 1 | 99.10 | n<2 | 99.07 | -0.03 | |
| QYB-2505-U5049 | Semaglutide | 03 May 2025 | 2025-Q3 | 8 | 99.36 | 0.85 | 98.84 | -0.52 | |
| QYB-2504-H5023 | GHRP-6 | 22 Apr 2025 | 2025-Q2 | 13 | 99.45 | 0.94 | 99.40 | -0.05 | |
| QYB-2503-W5265 | MK-677 (Ibutamoren mesylate) | 24 Mar 2025 | 2025-Q3 | 2 | 99.85 | 0.16 | 99.90 | +0.05 | |
| QYB-2502-V4343 | Pemvidutide | 28 Feb 2025 | 2025-Q3 | 2 | 98.74 | 0.15 | 99.25 | +0.51 | |
| QYB-2501-T4869 | Selank | 14 Jan 2025 | 2025-Q2 | 2 | 99.78 | 0.30 | 99.57 | -0.21 | |
| QYB-2501-C5179 | N-Acetyl Semax Amide | 06 Jan 2025 | 2025-Q2 | 9 | 99.72 | 0.43 | 99.17 | -0.55 | |
| QYB-2411-G5028 | N-Acetyl Semax Amide | 22 Nov 2024 | 2025-Q2 | 5 | 99.64 | 0.39 | 99.68 | +0.04 | |
| QYB-2410-S4374 | GHRP-6 | 31 Oct 2024 | 2024-Q4 | 8 | 99.83 | 0.53 | 99.90 | +0.07 | |
| QYB-2410-V4909 | Semaglutide | 16 Oct 2024 | 2025-Q1 | 4 | 99.63 | 0.50 | 99.41 | -0.22 | |
| QYB-2408-A4637 | Ipamorelin | 09 Aug 2024 | 2025-Q1 | 5 | 99.93 | 0.26 | 99.90 | -0.03 | |
| QYB-2408-A4387 | TB-500 | 08 Aug 2024 | 2025-Q1 | 1 | 99.68 | n<2 | 99.84 | +0.16 | |
| QYB-2407-E4769 | Ipamorelin | 27 Jul 2024 | 2024-Q4 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| QYB-2407-J3967 | TB-500 | 11 Jul 2024 | 2024-Q3 | 2 | 99.92 | 0.03 | 99.90 | -0.02 | |
| QYB-2404-W4423 | Sermorelin | 06 Apr 2024 | 2024-Q2 | 9 | 99.55 | 0.78 | 99.90 | +0.35 | |
| QYB-2403-T4551 | Tirzepatide | 13 Mar 2024 | 2024-Q3 | 6 | 99.28 | 0.56 | 99.60 | +0.32 | |
| QYB-2402-P4688 | Melanotan II | 21 Feb 2024 | 2024-Q2 | 2 | 99.89 | 0.09 | 99.64 | -0.25 | |
| QYB-2402-J4684 | Tirzepatide | 13 Feb 2024 | 2024-Q1 | 3 | 99.00 | 0.68 | 99.06 | +0.06 | |
| QYB-2312-K4892 | Retatrutide | 05 Dec 2023 | 2024-Q2 | 3 | 98.63 | 1.16 | 98.92 | +0.29 | |
| QYB-2311-U4037 | Semaglutide | 10 Nov 2023 | 2024-Q2 | 6 | 99.26 | 0.98 | 99.24 | -0.02 |